BKV

AlloVir Provides Updates on Phase 3 Clinical Development Program for Posoleucel, an Allogeneic Virus-Specific T Cell Therapy

Retrieved on: 
Friday, December 22, 2023

WALTHAM, Mass., Dec. 22, 2023 (GLOBE NEWSWIRE) -- AlloVir, Inc. (Nasdaq: ALVR), an allogeneic T cell immunotherapy company, today provided an update on its three Phase 3 clinical trials with posoleucel, an investigational off-the-shelf multi-virus-specific T cell therapy, which targets six viral pathogens in immunocompromised individuals: adenovirus (AdV), BK virus (BKV), cytomegalovirus (CMV), Epstein-Barr virus (EBV), human herpesvirus-6 (HHV-6) and JC virus (JCV). The company will discontinue its three global Phase 3 posoleucel studies – for prevention of clinically significant infections or diseases by multiple viruses, treatment of virus-associated hemorrhagic cystitis (vHC), and treatment of adenovirus (AdV) – following allogeneic hematopoietic cell transplant (allo-HCT). The company made the determination following three pre-planned analyses by three independent Data Safety Monitoring Boards (DSMBs) each of which recommended stopping its respective trial for futility after a review of the data suggested that each study was unlikely to meet its primary endpoint. There were no observed safety concerns raised by any of the DSMBs.

Key Points: 
  • The company will discontinue its three global Phase 3 posoleucel studies – for prevention of clinically significant infections or diseases by multiple viruses, treatment of virus-associated hemorrhagic cystitis (vHC), and treatment of adenovirus (AdV) – following allogeneic hematopoietic cell transplant (allo-HCT).
  • AlloVir is in the process of notifying regulatory agencies and clinical trial investigators involved in these trials of the findings.
  • “In light of the DSMB recommendations, we will discontinue the prevention, vHC and AdV Phase 3 trials.
  • As of September 30, 2023, AlloVir had cash, cash equivalents and short-term investments of $213.3 million.

This Week in Energy News: 10 Stories You Need to See

Retrieved on: 
Friday, November 17, 2023

NEW YORK, Nov. 17, 2023 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help journalists covering the energy and natural resources industry stay on top of the week's most newsworthy and popular releases, here's a roundup of stories from the week that shouldn't be missed.

Key Points: 
  • NEW YORK, Nov. 17, 2023 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire.
  • To help journalists covering the energy and natural resources industry stay on top of the week's most newsworthy and popular releases, here's a roundup of stories from the week that shouldn't be missed.
  • The list below includes the headline (with a link to the full text) and an excerpt from each story.
  • PSE's VPP will reduce costs and help maintain reliable energy supply to its more than 1 million residential and business customers.

BKV and EnLink Midstream Commence First Carbon Capture and Sequestration Project in the Barnett Shale

Retrieved on: 
Monday, November 13, 2023

The project is forecasted to achieve an average sequestration rate of up to approximately 210,000 metric tons of CO2e per year over the course of the project life.

Key Points: 
  • The project is forecasted to achieve an average sequestration rate of up to approximately 210,000 metric tons of CO2e per year over the course of the project life.
  • "We are thrilled to officially commence our Barnett Zero Project and begin our newest chapter - commercial CCS operations," said Chris Kalnin, Chief Executive Officer of BKV.
  • Through the project, BKV and EnLink will dispose of and geologically sequester CO2 generated as a byproduct of the production of BKV's natural gas in the Barnett Shale.
  • "The commencement of operations for the Barnett Zero project with BKV reflects tangible progress on EnLink's vision to create the future of midstream.

AlloVir Reports Third Quarter 2023 Financial Results

Retrieved on: 
Thursday, November 2, 2023

AlloVir, Inc. (Nasdaq: ALVR), a late-clinical stage allogeneic T cell immunotherapy company, today reported financial results from the third quarter ended September 30, 2023.

Key Points: 
  • AlloVir, Inc. (Nasdaq: ALVR), a late-clinical stage allogeneic T cell immunotherapy company, today reported financial results from the third quarter ended September 30, 2023.
  • “At AlloVir, we are dedicated to serving immunocompromised patients suffering from devastating and life-threatening viral diseases,” said Diana Brainard, M.D., Chief Executive Officer, AlloVir.
  • Research and development expenses were $34.2 million for the quarter ended September 30, 2023, compared with $30.0 million for the quarter ended September 30, 2022.
  • General and administrative expenses were consistent at $12.8 million for the quarter ended September 30, 2023, compared with $12.9 million for the quarter ended September 30, 2022.

Memo Therapeutics AG Raises CHF 25 Million Series C Financing to Complete Phase II Clinical Development of AntiBKV for BKV Infection in Renal Transplant Patients

Retrieved on: 
Thursday, November 2, 2023

Memo Therapeutics AG (“MTx”), a late-stage biotech company developing best-in-class therapeutic antibodies, announced today the closing of a CHF25 million Series C financing led by Pureos Bioventures.

Key Points: 
  • Memo Therapeutics AG (“MTx”), a late-stage biotech company developing best-in-class therapeutic antibodies, announced today the closing of a CHF25 million Series C financing led by Pureos Bioventures.
  • Phase II clinical development of its best- and first-in-class antibody, AntiBKV, intended to neutralize BK polyomavirus (“BKV”) infection in kidney transplant recipients.
  • BKV infection poses a significant threat following the transplantation procedure, with serious adverse effects on graft function and ultimately patient survival.
  • “With these new funds, we are in an optimal position to complete a multi-center Phase II study with AntiBKV, a treatment option that could dramatically improve the lives of renal transplant patients.

Bluewater Aviation Announces the Debut of its Build-To-Suit "Hangars at BKV" a Private Hangar Community

Retrieved on: 
Tuesday, October 10, 2023

TAMPA BAY, Fla., Oct. 10, 2023 /PRNewswire/ -- Bluewater Aviation is proud to debut the initial phase of its 12+ acre aviation development in the flourishing Tampa Bay region.

Key Points: 
  • TAMPA BAY, Fla., Oct. 10, 2023 /PRNewswire/ -- Bluewater Aviation is proud to debut the initial phase of its 12+ acre aviation development in the flourishing Tampa Bay region.
  • Bluewater Aviation is coming to the Brooksville-Tampa Bay Regional Airport (BKV) and is proud to announce that it is now accepting wait-list reservations for "The Hangars at BKV.
  • "  Early applicants can reserve a private hangar in our exclusive private hangar community.
  • Phase I will kickstart the first of several projects on Bluewater's 12+ acre campus at the east end of the 9/27 runway.

Project Canary and BKV Corporation Collaborate on CCUS Monitoring & Reporting

Retrieved on: 
Tuesday, October 10, 2023

DENVER, Oct. 10, 2023 /PRNewswire/ -- Project Canary, an enterprise emissions data platform that helps energy leaders identify, measure, understand, and act to reduce GHG emissions, today announced an expansion of its partnership with BKV Corporation to perform carbon assessment, monitoring, and reporting of their Barnett Zero project, BKV's first high concentration CCUS project.

Key Points: 
  • DENVER, Oct. 10, 2023 /PRNewswire/ -- Project Canary, an enterprise emissions data platform that helps energy leaders identify, measure, understand, and act to reduce GHG emissions, today announced an expansion of its partnership with BKV Corporation to perform carbon assessment, monitoring, and reporting of their Barnett Zero project, BKV's first high concentration CCUS project.
  • As part of the partnership, Project Canary will deploy its Digital Monitoring, Reporting, and Verification (dMRV) platform SENSE CCUS, which collects, measures, and provides visual analytics for emissions data across the CCUS value chain.
  • Building on the Canary SENSE emissions data platform, SENSE CCUS will provide real-time emissions-driven operational insights, monitoring, and data-driven reporting.
  • "The future of the low-carbon energy sector is moving to more granular and accurate measurement," said Nayeem Chowdhury, Head of CCUS at Project Canary.

EQS-News: AiCuris´ AiCubator Program Opens New Application Round for Innovative Projects with Focus on Treatment Options for Viral Infections in Immunocompromised Patients

Retrieved on: 
Thursday, September 28, 2023

AiCuris’ AiCubator program provides first-hand support for early research projects of young start-ups and academic teams that work on innovative treatment options for viral infections in immunocompromised patients.

Key Points: 
  • AiCuris’ AiCubator program provides first-hand support for early research projects of young start-ups and academic teams that work on innovative treatment options for viral infections in immunocompromised patients.
  • The fourth AiCubator application round starts on October 1st and will end on December 31st, 2023.
  • AiCuris’ AiCubator provides first-hand support for early research projects with a focus on innovative treatment options for viral infections in immunocompromised patients.
  • Interested parties can apply to the AiCubator program by filling in the AiCubator standard application form , describing the project, its status and development plans.

BKV and ENGIE Collaborate to Introduce Carbon Sequestered Gas

Retrieved on: 
Sunday, September 10, 2023

DENVER, Sept. 10, 2023 /PRNewswire/ -- BKV Corporation ("BKV") and ENGIE Energy Marketing NA, Inc, a subsidiary of global energy utility ENGIE S.A. (ENGIE), announced the signing of a contract for the sale and purchase of natural gas and associated Carbon Sequestered Credits, a new measured, third-party verified, carbon sequestered product.

Key Points: 
  • DENVER, Sept. 10, 2023 /PRNewswire/ -- BKV Corporation ("BKV") and ENGIE Energy Marketing NA, Inc, a subsidiary of global energy utility ENGIE S.A. (ENGIE), announced the signing of a contract for the sale and purchase of natural gas and associated Carbon Sequestered Credits, a new measured, third-party verified, carbon sequestered product.
  • Under the innovative arrangement, BKV will deliver to ENGIE physical natural gas, as well as an equivalent amount of gas tokens that represent the environmental attributes associated with both responsibly sourced gas (RSG) production and capturing carbon dioxide from the gas stream and injecting it into a permitted facility owned by BKV.
  • Under the contract terms, BKV is committed to deliver up to 10,000 MMBtu/day of independently certified Carbon Sequestered Gas to ENGIE.
  • "We are thrilled to collaborate with ENGIE to introduce a differentiated gas product to the energy industry," said Chris Kalnin, Chief Executive Officer of BKV.

BKV and NuQuest Energy Announce Carbon Sequestration Agreement with the State of Louisiana

Retrieved on: 
Thursday, August 10, 2023

DENVER, Aug. 10, 2023 /PRNewswire/ -- BKV Corporation (BKV) and NuQuest Energy LLC (NuQuest) announced today that they entered into a carbon sequestration agreement with the State of Louisiana to develop facilities and permanently sequester carbon dioxide from local emissions sources, supporting the goal to reduce their carbon footprints and supporting BKV's commitment toward achieving net-zero carbon emissions in its upstream businesses.

Key Points: 
  • DENVER, Aug. 10, 2023 /PRNewswire/ -- BKV Corporation (BKV) and NuQuest Energy LLC (NuQuest) announced today that they entered into a carbon sequestration agreement with the State of Louisiana to develop facilities and permanently sequester carbon dioxide from local emissions sources, supporting the goal to reduce their carbon footprints and supporting BKV's commitment toward achieving net-zero carbon emissions in its upstream businesses.
  • The State of Louisiana granted the carbon storage and sequestration rights on approximately 21,000 acres of land in St. Charles and Jefferson Parishes to High West Sequestration, LLC.
  • Carbon capture and sequestration is the process of capturing and permanently storing carbon dioxide, which reduces the amount of pollutive carbon dioxide in the atmosphere.
  • NuQuest Co-Founder Kirk Barrell said, "NuQuest Energy has levered its 120 years of petroleum industry experience to identify, evaluate, and develop a world class carbon sequestration site geographically focused on the Mississippi River corridor.